Ovarian cancer risk assessment: A tool for preoperative assessment

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 158, Issue 2, 2011, Pages 325-329

  Ronco, Deb A ^a   Manahan, Kelly J ^a   Geisler, John P ^a  

^a UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

Author keywords

CA 125; Ovarian neoplasms; Pelvic mass; Prealbumin; Transthyretin

Indexed keywords

CA 125 ANTIGEN; PREALBUMIN;

ARTICLE; CANCER RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OVARY CANCER; PELVIS; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 80053570255     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.05.018     Document Type: Article

References (21)

1. American College of Obstetricians and Gynecologists The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion No. 280 2002 ACOG Washington, DC
2. A.R. Mayer, S.K. Chambers, and E. Graves Ovarian cancer staging: does it require a gynecologic oncologist? Gynecol Oncol 47 1992 223 227 (Pubitemid 23001332)
3. T. Le, G.V. Krepart, R.J. Lotocki, and M.S. Heywood Does Debulking surgery improve survival in biologically aggressive ovarian carcinoma? Gynecol Oncol 07 1997 208 214 (Pubitemid 27500422)
4. S.M. Eisenkop, N.M. Spirtos, T.W. Montag, R.H. Nalick, and H. Wang The impact of subspecialty training on the management of advanced ovarian cancer Gynecol Oncol 47 1992 203 209 (Pubitemid 23001329)
5. A. Gadducci, M. Ferdeghini, and C. Prontera The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis Gynecol Oncol 44 1992 147 154
6. E.M. Posadas, B. Davidson, and E.C. Kohn Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature Curr Opin Oncol 16 2004 478 484 (Pubitemid 39159178)
7. E.L. Moss, J. Hollingworth, and T.M. Reynolds The role of CA125 in clinical practice J Clin Pathol 58 2005 308 312 (Pubitemid 40380329)
8. K. Lewandrowski Managing utilization of new diagnostic tests Clin Lead Manage Rev 17 2003 318 324
9. I. Jacobs, D. Oram, J. Fairbanks, J. Turner, C. Frost, and J.G. Grudzinskas A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer Br J Obstet Gynaecol 97 1990 922 929 (Pubitemid 20340625)
10. I. Visintin, Z. Feng, and G. Longton Diagnostic markers for early detection of ovarian cancer Clin Cancer Res 14 4 2008 1065 1072 (Pubitemid 351302552)
11. R.G. Moore, D.S. McMeekin, and A.K. Brown A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Gynecol Oncol 112 2009 40 46
12. T. Pulay, S. Csomor, I. Kovacs, G. Szarka, and P. Somos Changes of serum proteins in patients with malignant gynaecological tumours Acta Chir Hung 29 1988 305 314
13. J. Tosner, J. Krejsek, and B. Louda Serum prealbumin, transferin and alpha-1-acid glycoprotein in patients with gynecological carcinomas Neoplasma 35 1988 403 411 (Pubitemid 18264190)
14. J.H. Meerwaldt, W.G. Haije, E.H. Cooper, N.B. Pidcock, and M. Burg Biochemical aids in the monitoring of patients with ovarian cancer Gynecol Oncol 16 1983 209 218 (Pubitemid 13014834)
15. C.G. Mahlck, and K. Grankvist Plasma prealbumin in women with epithelial ovarian carcinoma Gynecol Obstet Invest 37 1994 135 140
16. J.C. Junqueira, E.C. Soares, H. Filho, N.F. Hoehr, D.O. Magro, and M. Ueno Nutritional risk factors for postoperative complications in Brazilian elderly patients undergoing major elective surgery Nutrition 19 2003 321 326 (Pubitemid 36390125)
17. Measurement of visceral protein status in assessing protein and energy malnutrition: standard of care. Prealbumin in Nutritional Care Consensus Group Nutrition 11 1995 169 171
18. S.S. Im, A.N. Gordon, and B.M. Buttin Validation of referral guidelines for women with pelvic masses Obstet Gynecol 105 2005 35 41 (Pubitemid 40189908)
19. S. Tingulstad, B. Hagen, and F.E. Skjeldestad Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses Br J Obstet Gynaecol 103 1996 826 831 (Pubitemid 26291762)
20. A.P. Davies, I. Jacobs, R. Woolas, A. Fish, and D. Oram The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index Br J Obstet Gynaecol 100 1993 927 931 (Pubitemid 23308278)
21. S. Tingulstad, B. Hagen, F.E. Skjeldestad, T. Halvorsen, K. Nustad, and M. Onsrud The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals Obstet Gynecol 93 1999 448 452 (Pubitemid 29107011)